Low potential of circulating interleukin 1 receptor antagonist as a prediction marker for squamous cell carcinoma of the head and neck

Low potential of circulating interleukin 1 receptor antagonist as a prediction marker for squamous cell carcinoma of the head and neck

Background: Circulating markers are attractive molecules for prognosis and management of cancer that allow sequential monitoring of patients during and after treatment. Based on previous protein profiling data, circulating interleukin 1 receptor antagonist (IL-1Ra) was evaluated as a potential diagn...

Full description

Bibliographic Details
Main Authors: Boldrup, L. (Author), Coates, P. (Author), Fåhraeus, R. (Author), Gu, X. (Author), Nylander, K. (Author), Sgaramella, N. (Author), Wang, L. (Author), Wilms, T. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
adult
age
aged
Article
body mass
cancer prognosis
cancer staging
Carcinoma, Squamous Cell
cohort analysis
comparative study
controlled study
electrochemiluminescence immunoassay
female
Head and Neck Neoplasms
head and neck squamous cell carcinoma
head and neck tumor
human
Humans
IL-1Ra
interleukin 1 receptor
Interleukin 1 Receptor Antagonist Protein
interleukin 1 receptor blocking agent
major clinical study
male
middle aged
people by smoking status
plasma
predictive value
Receptors, Interleukin-1
squamous cell carcinoma
Squamous Cell Carcinoma of Head and Neck
tongue carcinoma
tumor volume
upregulation
very elderly
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items